Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP)’s Basic Consolidated EPS Came In At $-0.3995

0

The annual basic consolidated EPS for Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) posted annual basic consolidated EPS of $-0.3995 for the year period ended2015-06-30. But basic consolidated EPS for the quarter period ended 2015-06-30 came in at $-0.3995.

What About EPS from continuing operations

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP)’s EPS from continuing operations for the annual period ended 2015-06-30 came in at -0.3995. On quarterly basis, EPS from continuing operations stood at $-0.3995 for the three-month period ended 2015-06-30.

EPS contribution from parent

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) received of $-0.3995 EPS boost from the parent company for the annual period ended 2015-06-30. For the quarter period ended 2015-06-30, the company received EPS boost of $-0.3995 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2015-06-30 was$-0.3783, but for the quarter period ended 2015-06-30 the basic net EPS was $-0.3783.

What About Consolidated Diluted EPS?

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) posted consolidated diluted EPS of $-0.3995 for the annual period ended 2015-06-30. On the other hand, consolidated diluted EPS for the quarterly period ended 2015-06-30 stood at $-0.3995.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $-0.3995 for the annual period ended 2015-06-30. On quarter basis, diluted EPS from continuing operations was $-0.3995 for the three-month period ended 2015-06-30.

Net diluted EPS

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) posted net diluted EPS of $-0.3783for the annual period ended 2015-06-30. On the other hand, it posted net diluted EPS of $-0.3783 for thequarterly period ended 2015-06-30.

What portion of diluted EPS came from parent?

For the annual period ended 2015-06-30, the parent company of Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) contributed diluted EPS of $-0.3995. The diluted EPS contribution from the parent for the quarter ended 2015-06-30 stood at $-0.3995.

The company’s net basic EPS for the annual period ended 2015-06-30 was $-0.42 while for the quarter period ended 2015-06-30 it was $-0.42.

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) had average basic shares outstanding of 54.169 for the annual period ended 2015-06-30 and 54.169 for the quarter period ended 2015-06-30.The number of diluted shares outstanding was 54.169 for the annual period ended 2015-06-30 and 54.169 for the quarter ended 2015-06-30.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 30 times, 1 visits today)